Along with the focus on prevention,
the WHI hormone therapy trials were largely studies of older women — in their 60s and 70s.
Recently, Manson and colleagues published a long - term study of the risk of death in women in the two
WHI hormone therapy trials — combined therapy and estrogen alone — from the time of trial enrollment in the mid-1990s until the end of 2014.
The WHI hormone therapy trials assessed heart disease, breast cancer, stroke, blood clots, colorectal cancer, hip fractures and deaths from other causes in women who used the hormones versus those who took a placebo.
Not exact matches
The trial, part of a multifaceted project called the Women's Health Initiative, or
WHI, was meant to examine
hormone therapy's effectiveness in lowering the risk of heart disease and other conditions in women ages 50 to 79.
The 2002
WHI report in JAMA, which described early results of the combined
hormone therapy, shocked the medical community.
Research in the last five years, including a long - term follow - up of women in the
WHI, has clarified the risks, benefits and ideal ages for
hormone therapy.
Then, in 2002, a 16,000 - women study named the Women's Health Initiative (
WHI) dropped a bombshell: participants were likelier to suffer from heart attacks and breast cancer if they took combination estrogen and progestin
hormones.
Researchers launched the
WHI in part to study the long - term effects of
hormone replacement.
«I was surprised by the magnitude of the effect — the doubling of breast density associated with combination -
hormone therapy,» said McTiernan, lead physician of the
WHI Clinical Coordinating Center, which is based at Fred Hutchinson.
On the basis of HERS and other secondary prevention trials, the American Heart Association recommended against initiating postmenopausal
hormones for the secondary prevention of cardiovascular disease.43 The American Heart Association made no firm recommendation for primary prevention while awaiting the results from randomized clinical trials such as
WHI, and stated that continuation of the treatment should be considered on the basis of established noncoronary benefits and risks, possible coronary benefits and risks, and patient preference.
«In the Womens Health Initiative (
WHI) trial, when women got seven years of estrogen alone, there was no increased risk of breast cancer, but after four to five years on combined
hormone therapy, the risk emerges,» she says.
The
WHI (women's health initiative) study was halted prematurely because of the negative effects caused by patented
hormones during the study.
Hormone Replacement Therapy Side Effects and HRT Research: The
WHI (Women's Health Initiative) The risks of conventional HRT outweigh the benefits, and major research, including the Women's Health Inititive (
WHI) and the Million Women Study have finally made that clear.
The massive switch was more a product of the rank and file Physicians who stopped writing prescriptions for Medroxyprogesterone (MPA), also called Provera ™, the synthetic
hormone used in the
WHI study.
Here's an article by Dr. John Lee about the pivotal Women's Health Initiative (
WHI) study, which once and for all showed by dangerous synthetic
hormones can be.
Again, we know from the 2002
WHI study that synthetic
hormones cause heart disease, and bioidentical
hormones do not.
(22) Monster
Hormones are Chemically Altered Chemically altered hormones were used in the WHI study, and are routinely handed out by the medical
Hormones are Chemically Altered Chemically altered
hormones were used in the WHI study, and are routinely handed out by the medical
hormones were used in the
WHI study, and are routinely handed out by the medical system.
What Was the Women's Health Initiative -
WHI Study The
WHI study was the large NIH sponsored medical study in which synthetic
hormones were given to women.
(20)(56)(57) The
WHI Culprit was the Synthetic Progestin (an altered form of Progesterone) Back to the first arm of the
WHI which used Prempro, it is clear from the data that the culprit which caused breast cancer and heart disease was Provera ™, a synthetic monster
hormone.
(7) The 2002
WHI (Women's Health Initiative) study revealed that synthetic
hormones increase the risk of breast cancer.
Therefore,
Hormone Replacement Therapy (HRT) medications do not fit into hormone cell receptors like BHRT medications; this mis - fit in molecular structure of HRT appears to have created some of the health problems associated with HRT Hormone Therapy which has been discussed in the media over the past few years (the Women's Health Initiative Study (WHI) was released in July 2002 indicating health risks associated with synthetic HR
Hormone Replacement Therapy (HRT) medications do not fit into
hormone cell receptors like BHRT medications; this mis - fit in molecular structure of HRT appears to have created some of the health problems associated with HRT Hormone Therapy which has been discussed in the media over the past few years (the Women's Health Initiative Study (WHI) was released in July 2002 indicating health risks associated with synthetic HR
hormone cell receptors like BHRT medications; this mis - fit in molecular structure of HRT appears to have created some of the health problems associated with HRT
Hormone Therapy which has been discussed in the media over the past few years (the Women's Health Initiative Study (WHI) was released in July 2002 indicating health risks associated with synthetic HR
Hormone Therapy which has been discussed in the media over the past few years (the Women's Health Initiative Study (
WHI) was released in July 2002 indicating health risks associated with synthetic HRT use).
(13) Immediately after this
WHI study was published in JAMA in 2002, there was a massive switch by women to bio-identical
hormones which resulted in a 4 billion dollar loss for Wyeth, the maker of Prempro ™.
Finally, in the
WHI Memory Study, women over age 65 who took
hormones were twice as likely to develop dementia as those taking a placebo.»
Compounding pharmacies — which are not FDA - approved, and make some 3 % of drugs dispensed in the U.S., according to WebMD — do not insert
WHI warnings with bioidentical
hormone packaging, giving the illusion of being safer than commercially marketed drugs.
When the Women's Health Initiative (
WHI) released results from its follow - up study of women who quit
hormone replacement therapy (see our previous article), not everyone got the message straight.
Premarin, a form of
hormone replacement therapy made from pregnant mare's urine by the Wyeth - Ayerst company, was one of the top - selling prescription medicines in the United States until the 2002 Women's Health Initiative (
WHI) study showed that PremPro (a combination of Premarin and a progestin) increased the risk of breast cancer, strokes, and gallbladder disease.
It's notable that since Dr. Lee first wrote his self - published book for doctors back in 1993, hundreds of studies, including the huge and now - famous National Institute of Health's Women's Health Initiative (
WHI), have thoroughly validated his stance on progesterone and conventional
hormone replacement therapy.